Revelation Biosciences Inc.

01/11/2022 | Press release | Archived content

Revelation Biosciences Inc. Announces Data Demonstrating REVTx-99 In Vitro Anti-Viral Activity Against SARS-CoV-2; Commencement of Trading as a Public Company